Usana Health Sciences (USNA) EBIAT (2016 - 2025)
Historic EBIAT for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to -$6.7 million.
- Usana Health Sciences' EBIAT fell 16280.76% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 6748.74%. This contributed to the annual value of $42.1 million for FY2024, which is 3406.28% down from last year.
- Per Usana Health Sciences' latest filing, its EBIAT stood at -$6.7 million for Q3 2025, which was down 16280.76% from $10.4 million recorded in Q2 2025.
- Usana Health Sciences' 5-year EBIAT high stood at $38.2 million for Q3 2021, and its period low was -$6.7 million during Q3 2025.
- Moreover, its 5-year median value for EBIAT was $16.5 million (2024), whereas its average is $16.6 million.
- Per our database at Business Quant, Usana Health Sciences' EBIAT surged by 3666.23% in 2021 and then plummeted by 16280.76% in 2025.
- Quarter analysis of 5 years shows Usana Health Sciences' EBIAT stood at $27.3 million in 2021, then crashed by 53.18% to $12.8 million in 2022, then surged by 31.04% to $16.8 million in 2023, then tumbled by 73.26% to $4.5 million in 2024, then tumbled by 248.57% to -$6.7 million in 2025.
- Its EBIAT was -$6.7 million in Q3 2025, compared to $10.4 million in Q2 2025 and $9.4 million in Q1 2025.